An interventional study of Early Time-Restricted Eating and Late Time-Restricted Eating in Time Restricted Eating and Intermittent Fasting, sponsored by German Institute of Human Nutrition. Recruiting at 1 site in Germany. Open to female participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-18.
Sponsored by German Institute of Human Nutrition · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Intermittent Fasting with a site in Germany — 9 open to participants now, 9 under way, none of them phase 3. Intermittent Fasting · Germany.
Among the 15 studies in Intermittent Fasting with a site in Germany, this one is the 8th largest by planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2024, is one of 13 with no phase, and was the 9th registered.
334 studies on the registry are indexed under Intermittent Fasting; 100 are open to participants now.
Browse Intermittent Fasting studies →9 of the 15 studies in Intermittent Fasting with a site in Germany are open now. Recruiting first, the newest first:
Charite University, Berlin, Germany · Sites in Germany
Ages 18+
Universität des Saarlandes · Sites in Germany
Ages 18–75
German Institute of Human Nutrition · Sites in Germany
Ages 18–75 · Healthy volunteers
Charite University, Berlin, Germany · Sites in Germany
Ages 60–85 · Healthy volunteers
Charite University, Berlin, Germany · Sites in Germany
Ages 18–75
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 73 Intermittent Fasting studies recruiting now, 19 (26%) set no upper age limit and 48 (66%) stop at 75 or younger; 4 take children under 18; 22 take healthy volunteers.
This study: 18 Years to 70 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 1 started in 2024.
This study's planned enrollment of 35 is below the median of 50 across 321 interventional studies indexed under Intermittent Fasting.
Median enrollment 50 across the 13 interventional studies, 92 across the 2 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 8 most frequent:
German Institute of Human Nutrition is the lead sponsor of 34 studies on the registry; 9 are open to participants now.
German Institute of Human Nutrition has 3 studies filed under Intermittent Fasting — fewer than ten, so there is no comparison to draw.
1 of the studies in Intermittent Fasting with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04607096University Hospital TuebingenIntermittent Fasting to Improve Insulin Secretion | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Intermittent Fasting with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to investigate how time-restricted eating (TRE), more specifically TRE at different times (early vs late in the day), influences brain activity, behavior, decision-making, food intake, physical activity, the gut microbiome and metabolic processes. The study intervention procedure is a replication of that described in Peters et al. (2021).
This study aims to investigate the effects of different time-restricted eating (TRE) interventions on decision-making, brain activity and related processes in an all female cohort over 8 weeks. The study will have a within-subjects, randomised, crossover design, involving two TRE interventions with a comparable feeding and fasting window of 8:16h respectively- early TRE (eating window: 08:00-16:00) and late TRE (eating window: 13:00-21:00). After completing a screening visit, participants will complete a two-week observational phase in which they record their habitual food intake, as well as sleep and physical activity assessment. After this observational phase, participants will be randomly assigned to one of two study arms (early TRE/late TRE or late TRE/early TRE). Here they will complete both TRE interventions for two weeks each, separated by a washout phase of two weeks. During these phases they will record their food intake and physical activity and sleep will be assessed. The participants will be invited for 4 laboratory study visits during this time, at the beginning and end of each TRE intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Early Time-Restricted Eating
Behavioral: Late Time-Restricted Eating
Eat between 8:00 and 16:00 for 2 weeks
Also known as: early TRE, eTRE, eTRF
Eat between 13:00 and 21:00 for 2 weeks
Also known as: late TRE, lTRE, lTRF
Behaviour: risk propensity on a decision-making task
The choice (accept/reject) between a risk/gamble or safe option, based on a task paradigm by Liu et al. (2021)
Time frame: 8 weeks
Brain: blood-oxygen-level-dependent (BOLD) signal changes
BOLD signal changes on a whole-brain level and in predefined regions of interest assessed using fMRI
Time frame: 8 weeks
Behaviour: Daily food intake
Self-reported food intake, recorded via FoodApp or handwritten food diary
Time frame: 8 weeks
Large Neutral Amino Acids (LNAAs)
Blood samples
Time frame: 8 weeks
Fasting glucose
Blood samples
Time frame: 8 weeks
Insulin
Blood samples
Time frame: 8 weeks
Questionnaire assessing sleep quality
Assessed by the Pittsburgh Sleep Quality Index (PSQI, Buysse et al. 1991). The questionnaire is scored between 0-21, with a higher value indicating worse sleep quality
Time frame: 8 weeks
Total Sleep Time (TST)
Assessed through an ActiGraph device
Time frame: 8 weeks
Sleep Efficiency (SE)
Assessed through an ActiGraph device
Time frame: 8 weeks
Wake After Sleep Onset (WASO)
Assessed through an ActiGraph device Sleep Onset Latency (SOL), Sleep Fragmentation Index
Time frame: 8 weeks
Sleep Onset Latency (SOL)
Assessed through an ActiGraph device
Time frame: 8 weeks
Sleep Fragmentation Index
Assessed through an ActiGraph device
Time frame: 8 weeks
Glucose tolerance
Assessed using an Oral Glucose Tolerance Test (OGTT). 5 blood samples will be carried out (fasted, 30 minutes, 60 minutes 120 minutes, 180 minutes after glucose consumption). Using these 5 values, area under curve (AUC) will be calculated to determine glucose tolerance
Time frame: 8 weeks
Total movement
24h activity, assessed using an ActiGraph device
Time frame: 8 weeks
Moderate to Vigorous Physical Activity (MVPA)
24h activity, assessed using an ActiGraph device
Time frame: 8 weeks
Non-sedentary Time
24h activity, assessed using an ActiGraph device
Time frame: 8 weeks
Step Count
24h activity, assessed using an ActiGraph device
Time frame: 8 weeks
Energy Expenditure
24h activity, assessed using an ActiGraph device
Time frame: 8 weeks
Daily questions monitoring intervention effects
Daily self-report questions of experience during intervention, level of physical activity, sleep quality, hunger and appetite levels, sleep and physical activity using Visual Analog Scales (VAS with a scale of 1-100, where higher values correspond to stronger e.g. hunger)
Time frame: 8 weeks
Questionnaires assessing chronotype
Munich Chronotype Questionnaire (MCTQ, Roenneberg et al. 2003), Morningness Eveningness Questionnaire (MEQ, Horne et al.1976)
Time frame: 8 weeks
Questionnaire assessing risk-taking behaviour
Domain Specific Risk-Taking (DOSPERT, Johnson et al. 2004)
Time frame: 8 weeks
Questionnaire assessing stress
Perceived Stress Questionnaire (PSQ, Fliege et al. 2001)
Time frame: 8 weeks
Questionnaire assessing intuitive eating
Intuitive Eating Scale (IES-2, Ruzanska et al. 2017)
Time frame: 8 weeks
Questionnaire assessing emotional eating
Salzburg Emotional Eating Questionnaire (SEES, Meule et al. 2018)
Time frame: 8 weeks
Questionnaire assessing food cravings
Food Cravings Questionnaire (FCQ, Meule et al. 2012)
Time frame: 8 weeks
Questionnaire assessing impulsive behaviour
Barratt Impulsivity Scale (BIS, Meule et al. 2011)
Time frame: 8 weeks
Questionnaire assessing momentary impulsive behaviour
Momentary Impulsivity Assessment (Tomko et al., 2014)
Time frame: 8 weeks
Questionnaire assessing behavioural inhibition and activation
Behavioural Inhibition and Activation (BIS/BAS, Strobel et al. 2001)
Time frame: 8 weeks
Questionnaire assessing mood
Positive and Negative Affect Scale (PANAS, Janke et al. 2014)
Time frame: 8 weeks
Questionnaire assessing interoception
Multidimension Assessment of Interoceptive Awareness (MAIA-2, Mehling et al. 2018)
Time frame: 8 weeks
Questionnaire assessing social decision-making
Social Value Orientation (SVO, Murphy et al. 2011)
Time frame: 8 weeks
Questionnaire assessing wellbeing
Warwick Edinburgh Mental Wellbeing Scale (WEMWBS, Lang et al. 2017)
Time frame: 8 weeks
Gut microbiome composition
Collection of stool samples before and after each intervention to assess gut microbiome composition including alpha and beta diversity
Time frame: 8 weeks
Decision-making
Delay discounting task: the task involves making choices between receiving two hypothetical monetary amounts: an immediate but smaller sum of money or a larger sum of money at a delayed, future point in time. The task paradigm is based on Wan et al. (2023) and Eisenstein et al. (2015).
Time frame: 8 weeks
Decision-making
Go/no-go task: the task involves responding to specific visual cues (go trial; press button) or inhibiting a response (no-go trial; don't press button) as fast as possible, assessing inhibitory control and impulsiveness
Time frame: 8 weeks
Cortisol
Blood samples
Time frame: 8 weeks
Progesterone
Blood samples
Time frame: 8 weeks
Estradiol
Blood samples
Time frame: 8 weeks
Ghrelin
Blood samples
Time frame: 8 weeks
Plan to share: Yes — Only anonymized data will be shared with the scientific community by making the anonymized data available via public servers (for example, Open Science Framework) when requested.
Supporting information: Statistical analysis plan
Time frame: Fully anonymised data will be available after publication of results when requested.
Access criteria: the anonymized data will be available via public servers (for example, Open Science Framework) when requested.
Started May 2024 (actual). Primary completion is estimated for Mar 2025, 10 months after the start.
Of 258 non-industry interventional studies with no phase under Intermittent Fasting, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 34. This study's planned 10 months is below that.
Counting every sponsor, half of 264 studies reached it within 17 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
German Institute of Human Nutrition